Abstract

Background: Aminosalicylates are the most frequently prescribed drugs for patients with Crohn’s disease (CD), yet evidence to support their efficacy as induction or maintenance therapy is controversial.

Tags

Epidemiology, Mesalamine, Adrenal Cortex Hormones, Crohn's Disease, Drug Therapy, therapeutic use, Immunosuppressive Agents, Biological Products, Adverse Effects

Read More